Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Sumera Rizvi"'
Autor:
Rory L. Smoot, Sumera Rizvi, Chen Wang, Daniel R. O'Brien, Ayano Kabashima, Caitlin B. Conboy, Nathan W. Werneburg, EeeLN H. Buckarma
SHP2 inhibition by NSC also shifts YAP from a cytoplasmic to nuclear compartment in a non-CCA cell line.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0305dd1a83b466a4ae36179001b321d
https://doi.org/10.1158/1541-7786.22514286
https://doi.org/10.1158/1541-7786.22514286
Autor:
Rory L. Smoot, Sumera Rizvi, Chen Wang, Daniel R. O'Brien, Ayano Kabashima, Caitlin B. Conboy, Nathan W. Werneburg, EeeLN H. Buckarma
Supplemental Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::451b60ea32ecf8af1c35765786e49fb1
https://doi.org/10.1158/1541-7786.22514280
https://doi.org/10.1158/1541-7786.22514280
Autor:
Rory L. Smoot, Sumera Rizvi, Chen Wang, Daniel R. O'Brien, Ayano Kabashima, Caitlin B. Conboy, Nathan W. Werneburg, EeeLN H. Buckarma
SHP1 does not appear to regulate pYAPY357 levels
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3021ca87611b073cd99dad35a54786b0
https://doi.org/10.1158/1541-7786.22514289.v1
https://doi.org/10.1158/1541-7786.22514289.v1
Autor:
Rory L. Smoot, Sumera Rizvi, Chen Wang, Daniel R. O'Brien, Ayano Kabashima, Caitlin B. Conboy, Nathan W. Werneburg, EeeLN H. Buckarma
RT-PCR primers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41bde55de3b1c84116676e060b8be97a
https://doi.org/10.1158/1541-7786.22514277
https://doi.org/10.1158/1541-7786.22514277
Autor:
Navtej S. Buttar, Martin E. Fernández-Zapico, Gwen Lomberk, Kenneth Wang, Luciana L. Almada, Zaheer Rizvi, Vladimir G. Gainullin, Andrea Comba, Cathrine J. DeMars, Sumera Rizvi
Supplementary Figure 1 from Combinatorial Chemoprevention Reveals a Novel Smoothened-Independent Role of GLI1 in Esophageal Carcinogenesis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b315fd9b6e47e694269dcdab9ce0777
https://doi.org/10.1158/0008-5472.22384949
https://doi.org/10.1158/0008-5472.22384949
Autor:
Orlee R. Guttman, Bettina E. Hansen, Sonya A. MacParland, Cynthia Levy, John M. Vierling, Pere Santamaria, Gideon M. Hirschfield, Maryam Ebadi, Fernanda de Quadros Onófrio, Angela Cheung, Jessica R. Allegretti, Nanda Kerkar, Wayne Bai, Catherine Vincent, Susan Gilmour, Amanda Ricciuto, Ashley Stueck, Fernando Alvarez, Mark G. Swain, Aldo J. Montano-Loza, Sumera Rizvi, Andrew Mason, Aliya Gulamhusein, David Jones
Publikováno v:
Canadian Liver Journal. 4:401-425
Autoimmune liver disease (AILD) spans a spectrum of chronic disorders affecting the liver parenchyma and biliary system. Three main categories of AILD are autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC), and primary sclerosing cholangitis
Autor:
N. Volkan Adsay, Sarah E. Kerr, Thomas W Czeczok, Rory L. Smoot, Taofic Mounajjed, Roger K. Moreira, Michelle D. Reid, Benjamin J. Van Treeck, Daniela S. Allende, Mira M Lotfalla, Rondell P. Graham, Maria Westerhoff, Bita V. Naini, Jaime I. Davila, Sumera Rizvi, Yuanhang Liu
Publikováno v:
Am J Clin Pathol
Objectives Mucinous cystic neoplasm of the liver is characterized by neoplastic mucinous and/or biliary epithelium surrounded by ovarian-type stroma. Immunohistochemical studies have shown that the ovarian-type stroma expresses estrogen receptor, sug
Autor:
Chen Wang, Rory L. Smoot, Sumera Rizvi, E. Buckarma, Nathan W. Werneburg, Caitlin B. Conboy, Daniel R. O'Brien, Ayano Kabashima
Publikováno v:
Mol Cancer Res
The Hippo pathway effector Yes-associated protein (YAP) is localized to the nucleus and transcriptionally active in a number of tumor types, including a majority of human cholangiocarcinomas. YAP activity has been linked to chemotherapy resistance an
Autor:
Sergio A. Gradilone, Mario Strazzabosco, Jesper B. Andersen, Cédric Coulouarn, Gregory J. Gores, Rocio I.R. Macias, John Bridgewater, Pedro M. Rodrigues, Vincenzo Cardinale, Lewis R. Roberts, Chiara Raggi, Chiara Braconi, Anja Moncsek, Jordi Bruix, Shahid A. Khan, Juan W. Valle, Marco Marzioni, Alejandro Forner, Angela Lamarca, Domenico Alvaro, Luca Fabris, Guido Carpino, Luke Boulter, Maria J. Perugorria, Joachim C. Mertens, Julie K. Heimbach, Sumera Rizvi, Eugenio Gaudio, Jesus M. Banales, Bas Groot Koerkamp, Jose J.G. Marin, Diego F. Calvisi, Pietro Invernizzi, Laura Fouassier
Publikováno v:
Nature Reviews Gastroenterology & Hepatology
Nature Reviews. Gastroenterology & Hepatology
Addi. Archivo Digital para la Docencia y la Investigación
Universidad de Cantabria (UC)
Nature Reviews Gastroenterology and Hepatology, 17(9), 557-588. Nature Publishing Group
Nature reviews. Gastroenterology & hepatology
Nature reviews. Gastroenterology & hepatology, Nature Publishing Group, 2009-, 2020, 17 (9), pp.557-588. ⟨10.1038/s41575-020-0310-z⟩
Nature reviews. Gastroenterology & hepatology, 2020, 17 (9), pp.557-588. ⟨10.1038/s41575-020-0310-z⟩
Banales, J M, Marin, J J G, Lamarca, A, Rodrigues, P M, Khan, S A, Roberts, L R, Cardinale, V, Carpino, G, Andersen, J B, Braconi, C, Calvisi, D F, Perugorria, M J, Fabris, L, Boulter, L, Macias, R I R, Gaudio, E, Alvaro, D, Gradilone, S A, Strazzabosco, M, Marzioni, M, Coulouarn, C, Fouassier, L, Raggi, C, Invernizzi, P, Mertens, J C, Moncsek, A, Rizvi, S, Heimbach, J, Koerkamp, B G, Bruix, J, Forner, A, Bridgewater, J, Valle, J W & Gores, G J 2020, ' Cholangiocarcinoma 2020 : the next horizon in mechanisms and management ', Nature Reviews. Gastroenterology & Hepatology, vol. 17, no. 9, pp. 557-588 . https://doi.org/10.1038/s41575-020-0310-z
Addi: Archivo Digital para la Docencia y la Investigación
Universidad del País Vasco
instname
Nature Reviews. Gastroenterology & Hepatology
Addi. Archivo Digital para la Docencia y la Investigación
Universidad de Cantabria (UC)
Nature Reviews Gastroenterology and Hepatology, 17(9), 557-588. Nature Publishing Group
Nature reviews. Gastroenterology & hepatology
Nature reviews. Gastroenterology & hepatology, Nature Publishing Group, 2009-, 2020, 17 (9), pp.557-588. ⟨10.1038/s41575-020-0310-z⟩
Nature reviews. Gastroenterology & hepatology, 2020, 17 (9), pp.557-588. ⟨10.1038/s41575-020-0310-z⟩
Banales, J M, Marin, J J G, Lamarca, A, Rodrigues, P M, Khan, S A, Roberts, L R, Cardinale, V, Carpino, G, Andersen, J B, Braconi, C, Calvisi, D F, Perugorria, M J, Fabris, L, Boulter, L, Macias, R I R, Gaudio, E, Alvaro, D, Gradilone, S A, Strazzabosco, M, Marzioni, M, Coulouarn, C, Fouassier, L, Raggi, C, Invernizzi, P, Mertens, J C, Moncsek, A, Rizvi, S, Heimbach, J, Koerkamp, B G, Bruix, J, Forner, A, Bridgewater, J, Valle, J W & Gores, G J 2020, ' Cholangiocarcinoma 2020 : the next horizon in mechanisms and management ', Nature Reviews. Gastroenterology & Hepatology, vol. 17, no. 9, pp. 557-588 . https://doi.org/10.1038/s41575-020-0310-z
Addi: Archivo Digital para la Docencia y la Investigación
Universidad del País Vasco
instname
Cholangiocarcinoma (CCA) includes a cluster of highly heterogeneous biliary malignant tumours that can arise at any point of the biliary tree. Their incidence is increasing globally, currently accounting for ~15% of all primary liver cancers and ~3%